Patients receiving dulaglutide were treated with a fixed dose of 1.5 mg once weekly, corresponding to the approved maintenance dose for glycemic control in T2D according to international guidelines and product labeling
A 2021 article in the Journal of Investigative Medicine highlighted the importance of identifying causative drugs for gastroparesis, especially since both diabetes and GLP-1RAs can delay gastric emptying, complicating diagnosis and treatment
In this study, the addition of GA substantially alleviated these effects and restored oxidant/antioxidant balance, bladder tone, and reducing inflammation and tissue damage
This is just a small summary of glutathiones benefits for the body and there are numerous other benefits in protecting the nervous system, helping the respiratory system, in protecting the heart and gastrointestinal tract especially in inflammatory bowel diseases
#BMD #DXA #Osteoporosis To view or add a comment, sign in 5,077 followers